XML 19 R5.htm IDEA: XBRL DOCUMENT v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2023 $ 54 $ 306,187 $ 529 $ (283,290) $ 23,480
Balance at the beginning (in shares) at Dec. 31, 2023 54,240,265        
Stock-based compensation   3,760     3,760
Issuance of common stock offerings, net of fees incurred $ 1 178     179
Issuance of common stock offerings, net of fees incurred (in shares) 382,823        
Common stock issued upon vesting of restricted stock units, less shares withheld to cover taxes   (7)     (7)
Common stock issued upon vesting of restricted stock units, less shares withheld to cover taxes (in shares) 207,058        
Issuance of warrants   691     691
Foreign currency translation adjustment     3,723   3,723
Net loss       (20,719) (20,719)
Balance at the end at Dec. 31, 2024 $ 55 310,809 4,252 (304,009) 11,107
Balance at the end (in shares) at Dec. 31, 2024 54,830,146        
Stock-based compensation   2,765     2,765
Issuance of common stock offerings, net of fees incurred $ 6 5,386     $ 5,392
Issuance of common stock offerings, net of fees incurred (in shares) 6,249,791        
Common stock issued upon vesting of restricted stock units, less shares withheld to cover taxes (in shares) 295,510        
Shares issued for exercise of stock options (in Shares) 11,650       11,650
Issuance of warrants   627     $ 627
Issuance of common stock from exercise of warrants $ 2 1,437     1,439
Issuance of common stock from exercise of warrants (in shares) 1,417,208        
Foreign currency translation adjustment     (7,229)   (7,229)
Net loss       (8,198) (8,198)
Balance at the end at Dec. 31, 2025 $ 63 $ 321,024 $ (2,977) $ (312,207) $ 5,903
Balance at the end (in shares) at Dec. 31, 2025 62,804,305